Ticker: AFL

Aflac

Finance Financials Insurance - Life

Price 125.60

Reco Hold Potential 60 Risk 47 Updated 2026-07-26

Official website

Forecast impact

played out

Target -14.0% target fill 116.3%

Reaction D5 -0.78% · D10 +3.42% market trust

Impact Potential 0 · Risk 0 valid until 2026-08-09

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Aflac is a financial services company primarily focused on supplemental insurance products. Its core offerings include accident, cancer, critical illness, and short-term disability insurance. The company operates mainly in the United States and Japan, with significant revenue generated from premiums and investment income. Aflac is recognized for its strong brand presence in the supplemental insurance market, catering to both individual and group policyholders.

Investment Profile

Aflac's stock may appeal to investors seeking dividends, given its consistent dividend yield. The company's focus on supplemental insurance positions it as a stable player in the financial sector, though recent revenue declines may indicate challenges. This stock is suitable for those looking for a balanced investment approach, considering its dividend payments alongside potential for moderate growth.

Category: Finance Sector: Financials Industry: Insurance - Life Investment style: Balanced Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-07-25

EPS (TTM) — earnings per share for the last 12 months, $: 8.80
Revenue QoQ — quarter-over-quarter revenue growth: -11.9%
EPS surprise: -2.2%
20d volatility: 0.8%
Dividend yield: 1.9%
last ex-date: 2026-05-20

AI recommendation changes

Date	Before	After	Reason
2026-07-17	Buy	Hold	Mixed fundamentals with moderate momentum; hold for now.
2026-07-09	Hold	Buy	Mixed fundamentals; cautious outlook amid market conditions.
2026-06-05	Sell	Hold	Mixed fundamentals with moderate momentum; hold for stability.
2026-05-28	Buy	Sell	Weak fundamentals and negative momentum raise concerns.
2026-05-22	Hold	Buy	Mixed signals; monitor fundamentals and market conditions closely.
2026-05-08	—	Hold	Weak fundamentals and mixed momentum signal caution.
2026-05-05	Buy	Hold	Компания Aflac демонстрирует стабильные показатели дивидендов и умеренный рост, однако недавнее снижение выручки и волатильность цен акций указывают на необходимость осторожности.
2026-03-27	Hold	Buy	Компания Aflac демонстрирует стабильный рост выручки и дивидендную доходность, однако недавние колебания цен и негативный сюрприз по прибыли могут указывать на краткосрочные риски.
2026-03-12	Buy	Hold	Компания Aflac демонстрирует стабильный рост выручки, однако недавние колебания цен и отрицательный сюрприз по прибыли могут указывать на неопределенность. Рекомендуется удерживать акции до более ясных сигналов о восстан
2026-01-30	Hold	Buy	Компания показывает положительную динамику на длительном горизонте, что свидетельствует о ее устойчивости. Умеренный риск связан с отсутствием данных по EPS и доходам, но текущая цена и тренды поддерживают покупку.
2026-01-29	Buy	Hold	Компания Aflac демонстрирует стабильный рост на длительном горизонте, однако недавние колебания цен и отсутствие данных по EPS и доходам могут указывать на неопределенность в краткосрочной перспективе.
2026-01-27	Hold	Buy	Компания Aflac демонстрирует положительную динамику на длительных горизонтах, что указывает на потенциал роста. Низкий риск и стабильные показатели делают её привлекательной для инвестиций.
2026-01-22	Buy	Hold	Компания Aflac демонстрирует стабильный рост за последние 120 дней, однако краткосрочные колебания цен и отсутствие данных по EPS и доходам могут указывать на неопределенность. Рекомендуется удерживать акции до получения

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-07-10	Jefferies	Target Raised	100 → 108	121.99
2026-07-09	Mizuho Securities	Target Raised	104 → 112	121.44
2026-07-08	UBS	Target Raised	114 → 124	121.27
2026-05-26	Piper Sandler	Target Raised	125 → 130	117.86
2026-05-21	Morgan Stanley	Target Raised	120 → 125	117.3
2026-05-04	Mizuho Securities	Target Raised	102 → 104	112.88
2026-04-30	Barclays	Target Lowered	101 → 99	116.21
2026-04-13	Mizuho Securities	Target Lowered	107 → 102	111.315
2026-04-09	UBS	Target Lowered	116 → 114	113.07
2026-02-09	Mizuho Securities	Target Raised	— → 107	113.2
2026-01-08	Barclays	Target Lowered	104 → 101	110.19
2025-12-30	Raymond James	Target Raised	110 → 119	109.96
2025-12-15	Morgan Stanley	Target Raised	118 → 120	111.76
2025-11-07	Evercore ISI	Target Raised	110 → 111	114.69
2025-11-05	Barclays	Target Raised	102 → 104	108.81
2025-10-09	Evercore ISI	Target Raised	106 → 110	111.9
2025-10-08	Barclays	Target Raised	100 → 102	112.93

News Page 1 of 1

Analysts Ritholtz Wealth Management highlight Travelers (TRV) as a top insurance stock following strong Q2 earnings

07/20/2026, 08:38 AM investing review Analysts: analysts, Ritholtz finance insurance Travelers Chubb Aflac

Travelers (TRV) has reported impressive earnings, significantly exceeding analyst expectations, which has led to a surge in its stock price. This performance highlights the strength of the insurance sector, particularly for companies that effectively leverage technology and maintain strong dividend growth.

Analysts Fairlead Strategies highlight bullish potential in insurance stocks including Travelers Companies (TRV), Progressive (PGR), and Aflac (AFL)

06/29/2026, 11:36 AM investing research Analysts: analysts finance Travelers Aflac Progressive

The insurance sector is showing signs of potential growth, with specific stocks poised for breakout, which could provide investors with opportunities for counter-trend outperformance in a broadening equity market.